- Home
- TALO vs ATAI Comparison
TALO vs ATAI Comparison
Compare TALO & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- ATAI
- Stock Information
- Founded
- TALO 2011
- ATAI 2018
- Country
- TALO United States
- ATAI Netherlands
- Employees
- TALO N/A
- ATAI N/A
- Industry
- TALO Oil & Gas Production
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- ATAI Health Care
- Exchange
- TALO Nasdaq
- ATAI Nasdaq
- Market Cap
- TALO 1.7B
- ATAI 1.6B
- IPO Year
- TALO N/A
- ATAI 2021
- Fundamental
- Price
- TALO $10.77
- ATAI $4.03
- Analyst Decision
- TALO Buy
- ATAI Strong Buy
- Analyst Count
- TALO 6
- ATAI 5
- Target Price
- TALO $14.50
- ATAI $14.00
- AVG Volume (30 Days)
- TALO 1.7M
- ATAI 7.0M
- Earning Date
- TALO 11-05-2025
- ATAI 11-12-2025
- Dividend Yield
- TALO N/A
- ATAI N/A
- EPS Growth
- TALO N/A
- ATAI N/A
- EPS
- TALO N/A
- ATAI N/A
- Revenue
- TALO $1,872,554,000.00
- ATAI $3,018,000.00
- Revenue This Year
- TALO N/A
- ATAI $736.04
- Revenue Next Year
- TALO N/A
- ATAI N/A
- P/E Ratio
- TALO N/A
- ATAI N/A
- Revenue Growth
- TALO 0.06
- ATAI 811.78
- 52 Week Low
- TALO $6.23
- ATAI $1.15
- 52 Week High
- TALO $12.13
- ATAI $6.75
- Technical
- Relative Strength Index (RSI)
- TALO 64.72
- ATAI 31.36
- Support Level
- TALO $10.37
- ATAI $4.14
- Resistance Level
- TALO $10.81
- ATAI $4.65
- Average True Range (ATR)
- TALO 0.38
- ATAI 0.34
- MACD
- TALO 0.10
- ATAI -0.17
- Stochastic Oscillator
- TALO 90.02
- ATAI 3.65
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.